A full understanding of this novel cellular degradation pathway holds the potential for identification of new strategies for treating Ebola virus disease (EVD) by shutting down Ebolavirus GP1,2 expression through enhanced degradation. The gene discussed is GTPBP1; the disease is Ebola hemorrhagic fever.